Dyslipidemia-related Risk Factors in Dialysis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02072837|
Recruitment Status : Completed
First Posted : February 27, 2014
Last Update Posted : February 28, 2014
|Condition or disease|
|Chronic Renal Disease Cardiovascular Disease Dyslipidemia|
Blood samples were obtained by venipuncture in the peritoneal dialyzed patients and control group in a twelve hours fasting state.In hemodialyzed patients blood was drawn just before the start of the mean weekly dialysis session also in a twelve hours fasting state from the vascular access.
All samples were received once at baseline time ( in the start of the study ). Peripheral systolic and diastolic blood pressures were calculated as an average of 10 measurements during a renal replacement treatment month in the starting time of the study.
Also, electrocardiographic examination, echocardiography and the calculation of ankle-brachial blood pressure index became once in the start of the study.
|Study Type :||Observational|
|Actual Enrollment :||96 participants|
|Official Title:||Dyslipidemia-related Variables as Risk Factor for Cardiovascular Disease in Patients on the End-stage of Renal Disease|
|Study Start Date :||January 2012|
|Actual Primary Completion Date :||January 2014|
|Actual Study Completion Date :||January 2014|
- Associations between dyslipidemia with cardiovascular disease on patients on renal replacement therapy [ Time Frame: February 2014 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02072837
|Principal Investigator:||Vaia D. Raikou, Ph.D||National & Kapodistrian University of Athens, School of Medicine|